Fused Deposition Modeling (FDM) 3D Printing of the Thermo-Sensitive Peptidomimetic Drug Enalapril Maleate.

FDM 3D printing analytics of extrudates and 3D printed tablets decomposition hot-melt extrusion oral dosage form personalized medicine thermo-sensitive drug

Journal

Pharmaceutics
ISSN: 1999-4923
Titre abrégé: Pharmaceutics
Pays: Switzerland
ID NLM: 101534003

Informations de publication

Date de publication:
08 Nov 2022
Historique:
received: 10 10 2022
revised: 28 10 2022
accepted: 03 11 2022
entrez: 11 11 2022
pubmed: 12 11 2022
medline: 12 11 2022
Statut: epublish

Résumé

Fused deposition modeling (FDM) 3D printing was used to produce 3D printed tablets with the thermo-sensitive model peptidomimetic drug enalapril maleate (EM). Two different formulations were prepared to investigate the degradation of enalapril maleate during the FDM 3D printing process. Soluplus

Identifiants

pubmed: 36365230
pii: pharmaceutics14112411
doi: 10.3390/pharmaceutics14112411
pmc: PMC9695326
pii:
doi:

Types de publication

Journal Article

Langues

eng

Subventions

Organisme : Federal Ministry of Education and Research
ID : 13XP5064B

Références

Eur J Pharm Biopharm. 2002 Sep;54(2):249-54
pubmed: 12191699
Pharmaceutics. 2021 Sep 21;13(9):
pubmed: 34575600
J Pharm Biomed Anal. 2008 Aug 5;47(4-5):934-7
pubmed: 18472382
Int J Pharm. 2022 Apr 25;618:121662
pubmed: 35292399
Pharmaceutics. 2020 Feb 03;12(2):
pubmed: 32028732
Pharm Res. 2018 Apr 20;35(6):124
pubmed: 29679157
AAPS PharmSciTech. 2021 Jan 17;22(1):49
pubmed: 33458797
Eur J Pharm Sci. 2014 May 13;55:1-11
pubmed: 24456933
Ther Innov Regul Sci. 2022 Nov;56(6):910-928
pubmed: 34826120
Int J Pharm. 2016 Nov 20;513(1-2):659-668
pubmed: 27640246
Pharm Res. 2016 Aug;33(8):1817-32
pubmed: 27194002
APMIS. 2019 May;127(5):386-424
pubmed: 31124204
Pharm Res. 2016 Nov;33(11):2704-12
pubmed: 27506424
Int J Pharm. 2018 Jul 10;545(1-2):144-152
pubmed: 29705104
Explor Res Clin Soc Pharm. 2021 Sep 25;4:100073
pubmed: 35479838
Pharmaceutics. 2019 Apr 22;11(4):
pubmed: 31013578
Pharmaceutics. 2022 Sep 30;14(10):
pubmed: 36297525
ACS Appl Mater Interfaces. 2012 Aug;4(8):4331-7
pubmed: 22839659
Sci Rep. 2021 Mar 16;11(1):5959
pubmed: 33727627
Pharmaceutics. 2021 Mar 09;13(3):
pubmed: 33803163
Curr Pharm Des. 2018;24(42):4957-4978
pubmed: 30520369
Eur J Pharm Sci. 2019 Mar 1;129:110-123
pubmed: 30610954

Auteurs

Lena Hoffmann (L)

Institute of Pharmaceutics and Biopharmaceutics, Heinrich Heine University, Universitätsstraße 1, 40225 Düsseldorf, Germany.

Jörg Breitkreutz (J)

Institute of Pharmaceutics and Biopharmaceutics, Heinrich Heine University, Universitätsstraße 1, 40225 Düsseldorf, Germany.

Julian Quodbach (J)

Institute of Pharmaceutics and Biopharmaceutics, Heinrich Heine University, Universitätsstraße 1, 40225 Düsseldorf, Germany.
Department of Pharmaceutics, Utrecht University, Universiteitsweg 99, 3584 CG Utrecht, The Netherlands.

Classifications MeSH